ImmuDyne, Inc. Filing With the Securities and Exchange Commission

MT. KISCO, N.Y., July 5, 2012 (GLOBE NEWSWIRE) -- Immudyne, Inc. (Pink Sheets:IMMD) a leading industry provider of all-natural products for immune system support from yeast beta-glucan, today announced the Company will prepare and file with the Securities and Exchange Commission ("SEC") a Registration Statement on Form 10, relating to the Company becoming a reporting company under Section 12(g) of the Securities Exchange Act of 1934, as amended.